Florence Brown, MD
Joslin Diabetes Center
Boston, MA
Nancy Drobycki, MSN, RN, CDCES
UT Southwestern Medical Center of Dallas
Diabetes Management Program
Dallas, TX
Chloe Zera, MD, MPH
Beth Israel Deaconess Medical Center
Obstetrics and Gynecology
Boston, MA
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
- Florence Brown, MD: Dexcom, research funding
The following faculty reported no relevant financial relationships: Nancy Drobycki, MSN, RN, CDCES; Chloe Zera, MD, MPH
The following subject matter experts who developed the clinical practice guideline used to create this activity reported the following relevant financial relationships:
- Rosa Corcoy, MD, PhD: Novo Nordisk, Consultant; Eli Lilly, Speaker, Research funding; Diabeloop, Speaker; Ascensia, Speaker; Sanofi, Speaker; Merck, Speaker; ONALABS, Consultant
- Gian Carlo Di Renzo, MD, PhD: Organon, Consultant; Nestle, Advisory Board;
- Alexandra Kautzky-Willer, MD: Bohringer Ingelheim, Consultant, Advisory Board; AstraZeneca, Consultant; Sanofi, Consultant; Novo Nordisk, Consultant; Research funding; Novartis, Consultant; Eli Lilly, Consultant, Advisory Board; Amgen, Consultant
- Adam Tabak, MD, PhD: Bohringer Ingelheim, Consultant; 77 Elektronika Kft13, Speaker; AstraZeneca, Speaker; Sanofi-Aventis, Consultant
The following subject matter experts who developed the clinical practice guideline used to create this activity reported no relevant financial relationships: Jennifer Wyckoff, MD; Annunziata Lapolla, MD; Bernadette Asias-Dinh, MD; Linda Barbour, MD, MSPH; Patrick Catalano, MD; Melanie Stephenson-Gray; Emily Weatherup, MS, RDN, CDCES; M Hassan Murad, MD, MPH; Naykky Singh Ospina, MD
The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.